Benzinga | Jan 28, 2022 05:09AM EST

RBC Capital Upgrades ResMed to Sector Perform, Announces $241 Price Target

RBC Capital upgrades ResMed (NYSE:RMD) from Underperform to Sector Perform and announces $241 price target.